Cholesterol Med, Fenofibrate, Might Slow Vision Loss in People With Diabetes

TUESDAY, June 25, 2024 -- A well-established cholesterol-lowering drug appears to significantly slow the progression of a diabetes-related eye disease, a new trial shows.

Fenofibrate (Tricor) has been approved since 2004 as a means of lowering...